3 Min Read
NEW YORK (Reuters) - Oil slipped for a fourth day on Wednesday, weighed down by expectations of weaker demand in Europe and by rising U.S. crude inventories.
FILE PHOTO: A sticker reads crude oil on the side of a storage tank in the Permian Basin in Mentone, Loving County, Texas, U.S. November 22, 2019. REUTERS/Angus Mordant/File Photo
Several European countries have paused the use of AstraZeneca’s COVID-19 vaccine on worries over possible side effects. Germany is seeing rising coronavirus cases, Italy is imposing a nationwide Easter lockdown and France plans to enforce tougher curbs.
“The suspension will not do the bloc’s economic and fuel recovery any favours,” said Stephen Brennock of oil broker PVM. “The hope now is that Europe can get its sluggish vaccine rollout back on track.”
(Updates prices)
LONDON, March 16 (Reuters) - Copper prices slumped on Tuesday as investors shed some of their bullish positions on uncertainty ahead of central bank meetings.
Benchmark copper on the London Metal Exchange (LME) had dropped 1.9% to $8,970 a tonne by 1700 GMT while prices on Comex fell 1.6% to $4.075 per pound.
Copper hit a 9-1/2 year peak of $9,617 last month, having surged by 24% since the start of the year.
“There’s lots of positive news already priced in, lots of positive expectations about electric vehicles. It’s quite natural for some of the smart money to take profits or stay on the sidelines,” said Xiao Fu, head of commodity market strategy at Bank of China International.
Message :
Required fields
NORTH CHICAGO, Ill., March 17, 2021 /PRNewswire/ AbbVie (NYSE:ABBV), a global research and development-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic arthritis. The updated Prescription Drug User Fee Act (PDUFA) action date has been extended three months to late Q2 2021.
AbbVie recently received an information request from the FDA for an updated assessment of the benefit-risk profile for upadacitinib in psoriatic arthritis. AbbVie responded to the request and the FDA will require additional time for a full review of the submission.
Global Fully Charged sector moving towards a sustainable future: By Kalkine Pty Limited
SYDNEY, March 18, 2021 /PRNewswire/ With more focus on an Electrified World , and policymakers paving way for a sustainable future, Battery-Storage Technologies Space seems to be the next wave of a frenzy to mitigate climate-change. The role of batteries in enabling a Global Green Economy vision over the next-decade is a big question here. The battery industry is still in the nascent-stage of innovation and can act as a key enabler transforming the transportation and power sector to create an emission-free environment.
In the hindsight, Kalkine s Global Fully Charged , or Battery Sector information provides insights on diverse quality battery-storage companies.
Gecina: Conditions for accessing the 2020 Universal Registration Document
Gecina (Paris:GFC):
The Universal Registration Document for 2020 was filed with the French securities regulator (Autorité des marchés financiers, AMF) on March 16, 2021.
It may be consulted on or downloaded from the following internet sites:
Gecina (www.gecina.fr), in the section Investors Publications and press releases Financial reports and universal registration document;
- AMF (www.amf-france.org).
by mail: Gecina 16, rue des Capucines, 75002 Paris, France;
- by email: actionnaire@gecina.fr;
The following documents are included in the Universal Registration Document:
the annual fiSnancial report for 2020;
- the 2020 integrated report
- the statutory auditors reports;